Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection (vol 30, pg 623, 2012)

被引：1
|
作者：
Tsan, Y-T
Lee, C-H
Wang, J-D
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 24期
关键词：
D O I：
10.1200/JCO.2013.52.6491
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3049 / 3049
页数：1
相关论文
共 50 条
  • [21] Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Huang, Rui
    Wang, Jian
    Wu, Weihua
    Yan, Xiaomin
    Wu, Chao
    [J]. HEPATOLOGY, 2020, 71 (06) : 2173 - 2174
  • [22] Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma
    Kew, M. C.
    [J]. PATHOLOGIE BIOLOGIE, 2010, 58 (04): : 273 - 277
  • [23] Association between hepatitis B and E virus infection and hepatocellular carcinoma risk
    Xue, Meng
    Lin, Xiaona
    Lin, Qiu-Xiong
    Pu, Xiaoyong
    Liu, Jiumin
    Li, Xing-Fang
    Hou, Jun
    Liu, Xudong
    Chen, Ren
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (12) : 2974 - 2981
  • [24] Prevention of hepatocellular carcinoma in hepatitis B virus infection
    Lim, Seng Gee
    Mohammed, Rosmawati
    Yuen, Man-Fung
    Kao, Jia-Horng
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (08) : 1352 - 1357
  • [25] Virus integration into the genomes of hepatocellular carcinoma patients with occult Hepatitis B virus infection
    Tatsuno, Kenji
    Midorikawa, Yutaka
    Takayama, Tadatoshi
    Nagae, Genta
    Yamamoto, Shogo
    Moriyama, Mitsuhiko
    Nakagawa, Hayato
    Koike, Kazuhiko
    Moriya, Kyoji
    Aburatani, Hiroyuki
    [J]. CANCER SCIENCE, 2018, 109 : 1288 - 1288
  • [26] Comparative risk of hepatocellular carcinoma from hepatitis C versus hepatitis B virus infection
    Hsu, Yao-Chun
    Wu, Chun-Ying
    Ho, Hsiu J.
    Lin, Jaw-Town
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 411 - 411
  • [27] RISK PREDICTION OF NON-CIRRHOTIC HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
    Jeng, W. -J.
    Yang, H. I.
    Liu, J.
    Lee, M. -H.
    Jen, C. -L.
    Batrla-Utermann, R.
    Lu, S. -N.
    Wang, L. -Y.
    You, S. -L.
    Chen, C. -J.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S545 - S545
  • [28] Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection
    Chen, Chi-Jen
    Yang, Yao-Hsu
    Lin, Meng-Hung
    Lee, Chuan-Pin
    Tsan, Yu-Tse
    Lai, Ming-Nan
    Yang, Hsiao-Yu
    Ho, Wen-Chao
    Chen, Pau-Chung
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (07) : 1578 - 1587
  • [29] High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Ohata, K
    Hamasaki, K
    Toriyama, K
    Ishikawa, H
    Nakao, K
    Eguchi, K
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (06) : 670 - 675
  • [30] The risk factors for mortality in patients with hepatitis B virus infection and hepatocellular carcinoma following liver transplantation
    Myer, Parvathi
    Samuelson, Andrew
    Morgan, Maureen
    Lee, Maximilian
    Kamal, Ahmad
    Ahmed, Aijaz
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S159 - S160
12345